A. Cumpston

发表

Further Evidence of an Association Between the Ratio of Substance P to 5-HIAA/Cr and Delayed Chemotherapy-induced Vomiting

G. Higa, G. Hobbs, M. Auber, 2014 .

Treatment of severe mucositis pain with oral ketamine mouthwash

S. Wen, A. Kanate, M. Hamadani, 2016, Supportive Care in Cancer.

Evaluation of Extended Interval Dosing Aminoglycosides in the Morbidly Obese Population

G. Hobbs, Jennifer L. Tharp, A. Cumpston, 2013, Advances in pharmacological sciences.

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)

S. Wen, A. Kanate, M. Hamadani, 2017, Bone Marrow Transplantation.

Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy‐era with plerixafor and G‐CSF has superior efficacy but significantly higher costs compared to mobilization with low‐dose cyclophosphamide and G‐CSF

F. Awan, K. Watkins, W. Tse, 2013, Journal of clinical apheresis.

Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies

F. Awan, K. Watkins, M. Hamadani, 2013, Bone Marrow Transplantation.

Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies.

F. Awan, K. Watkins, M. Hamadani, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.

Sonali M. Smith, A. Zelenetz, J. Friedberg, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit

G. Hobbs, S. Ericson, A. Sarwari, 2007, Bone Marrow Transplantation.

Extended follow‐up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit

J. Abraham, M. Hamadani, A. Sarwari, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Toxicity assessment of concurrent gabapentin/pregabalin administration with high-dose melphalan in autologous hematopoietic cell transplant recipients

S. Wen, J. Angus, A. Cumpston, 2021, Supportive Care in Cancer.

Delayed-onset effect of clofarabine in the treatment of an adult patient with acute myeloid leukemia

A. Kanate, J. Vos, A. Cumpston, 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Comparison of Clofarabine-Based Regimens Versus Etoposide Plus Mitoxantrone as Salvage Chemotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

S. Wen, A. Kanate, A. Cumpston, 2020, Archives of Hematology and Blood Diseases.

Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.

P. Hari, M. Pasquini, M. Horowitz, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease.

W. Petros, S. Remick, L. Gibson, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of anti‐anaerobic antibiotic activity on graft‐versus‐host disease in allogeneic hematopoietic stem cell transplant (HSCT) recipients at an institution that utilizes antibiotic cycling

S. Wen, A. Kanate, D. Slain, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.

M. Norkin, S. Mineishi, M. Krem, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma.

P. Hari, M. Pasquini, A. D’Souza, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation.

J. Abraham, S. Remick, L. Gibson, 2011, Hematology/oncology and stem cell therapy.

Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization

F. Awan, M. Hamadani, M. Craig, 2012, Journal of oncology.

Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies

S. Wen, A. Kanate, M. Hamadani, 2015, Antimicrobial Agents and Chemotherapy.

Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis.

M. Hamadani, D. Slain, M. Craig, 2012, International journal of antimicrobial agents.

A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis.

D. Slain, M. Craig, A. Cumpston, 2011, International journal of antimicrobial agents.

Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation

S. Wen, A. Kanate, Xiaoxiao Lu, 2017, Leukemia research and treatment.

Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients

A. Kanate, M. Hamadani, M. Craig, 2014, Annals of Hematology.

Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients

R. Turner, W. Petros, S. Wen, 2016, Antimicrobial Agents and Chemotherapy.

Single versus double‐unit transfusion: Safety and efficacy for patients with hematologic malignancies

P. Perrotta, S. Wen, A. Kanate, 2019, European journal of haematology.

Use of rituximab in refractory autoimmune thrombocytopenia following an autologous stem cell transplant

R. Altaha, A. Cumpston, S. Price, 2006, Hematology.

Evaluation of the pharmacokinetic interaction between letermovir and tacrolimus in allogeneic hematopoietic cell transplant recipients.

A. Cumpston, L. Veltri, K. Ross, 2022, Transplantation and cellular therapy.

Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood Transplantation.

P. Hari, M. Pasquini, A. Szabo, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use.

S. Wen, K. Watkins, A. Kanate, 2015, Cytotherapy.

Pharmacology of Drugs Used in Hematopoietic Cell Transplantation

A. Cumpston, M. Bodge, Megan N Bodge, 2019, Hematopoietic Cell Transplantation for Malignant Conditions.

Impact of body mass index (BMI) on the efficacy of plerixafor for hematopoietic progenitor cell (HPC) mobilization

S. Wen, A. Cumpston, L. Veltri, 2022, Bone Marrow Transplantation.

Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan‐based reduced toxicity conditioning

C. Hofmeister, R. Garzon, G. Phillips, 2011, Hematological oncology.

Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin

M. Regier, W. Tse, M. Hamadani, 2013, Bone marrow research.

Salvage bone marrow harvest in patients failing plerixafor-based stem cell mobilization attempt: feasibility and autologous transplantation outcomes.

K. Watkins, A. Kanate, M. Hamadani, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

INSTRUCTOR'S GUIDE TO CHANGES IN THIS EDITION

A. Cumpston, 2011 .

Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit.

M. Hamadani, M. Craig, Michael Sweet, 2012, American journal of infection control.

Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)

P. Hari, M. Pasquini, M. Horowitz, 2016 .

Bendamustine-Associated Hemolytic Anemia

S. Remick, A. Kanate, A. Cumpston, 2009, The Annals of pharmacotherapy.

Azacitidine-associated Sweet's syndrome.

M. Craig, A. Cumpston, H. Trickett, 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients

S. Wen, A. Kanate, M. Craig, 2019, Clinical hematology international.

Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia

A. Kanate, M. Craig, A. Cumpston, 2017, Advances in hematology.

Impact of Antiviral Prophylaxis Duration On Varicella Zoster Virus Infection Rates in Recipients of Autologous Hematopoietic Cell Transplantation

A. Kanate, M. Hamadani, M. Craig, 2013 .

Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population

J. Rogers, M. Craig, M. Newton, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Cost and Efficacy of Upfront Plerixafor Versus a “Just-in-Time” (JIT) Approach in Hematopoietic Progenitor Cell (HPC) Mobilization

S. Wen, K. Watkins, A. Kanate, 2014 .

Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation.

S. Wen, A. Kanate, M. Hamadani, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patients

A. Kanate, Michael Sweet, A. Cumpston, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

M. Hamadani, M. Craig, Michael Sweet, 2012, American journal of infection control.

Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis.

M. Hamadani, D. Slain, M. Craig, 2012, International journal of antimicrobial agents.

Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan‐based reduced toxicity conditioning

C. Hofmeister, R. Garzon, G. Phillips, 2011, Hematological oncology.

Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients

R. Turner, S. Wen, M. Hamadani, 2016, Antimicrobial Agents and Chemotherapy.

Reduction in Utilization and Costs Associated with Formulary Restrictions of Injectable Calcitonin

Bcop, Pharmd, A. Cumpston, 2020 .